Latest filing published 03 Jul 2025 for Evolent Health, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John Paul Johnson: trading record in brief
John Paul Johnson is a declared insider of Evolent Health, Inc. (finance chief), with filings sourced from SEC (Form 4). Over a trading history stretching from 2 March 2020 to 1 July 2025, the count stands at 24 filings.
The open-market record consists of 2 sales worth €1.8M, with no purchase. The rest of the record consists of 21 share grants and 1 option exercise.
The record was last updated on 3 July 2025 with a share grant in Evolent Health, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Paul Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,461 shares0Class A Common StockSEC:0001628908-25-000100:0
- 9,246 shares@ US$8.994.2% of flowClass A Common StockSEC:0001628908-25-000022:0
- 44,693 shares@ US$30.0063.4% of flowClass A Common StockSEC:0001628908-24-000094:0
- 12,123 shares0Class A Common StockSEC:0001628908-24-000034:0
- 44,000 shares0Class A Common StockSEC:0001628908-24-000021:0
- 20,413 shares0Class A Common StockSEC:0001628908-23-000039:0
- 44,000 shares0Class A Common StockSEC:0001628908-23-000023:0
- 18,434 shares@ US$34.1132.4% of flowClass A Common StockSEC:0001628908-22-000118:0
- 71,716 shares0Class A Common StockSEC:0001628908-22-000043:0
- 24,000 shares0Class A Common StockSEC:0001628908-22-000039:0
10 of 10 declarations
